MingTanMD
Infectious Disease • Irvine, CAProfessor, Microbiology & Molecular Genetics, University of California, Irvine, School of Medicine
Dr. Tan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UC Irvine Dept Of Microbiology & Molecular Genetics
B240 Med Sci
Irvine, CA 92697Phone+1 949-824-3397
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1985 - 1989
Johns Hopkins University School of MedicineClass of 1985
University of California (San Francisco)Fellowship, Infectious Disease
Certifications & Licensure
CA State Medical License 1989 - 2026
OH State Medical License 1986 - 1990- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 748 citationsTargeting cellular metabolism to improve cancer therapeuticsYuhua Zhao, Ethan B. Butler, Ming Tan
Cell Death & Disease. 2013-03-07 - 102 citationsImmunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1αSangbin Lim, Hao Liu, Luciana Madeira da Silva, Ritu Arora, Zixing Liu
Cancer Research. 2016-04-15 - 59 citationsA Pilot Study of Protracted Topotecan Dosing Using a Pharmacokinetically Guided Dosing Approach in Children with Solid TumorsVictor M. Santana, William C. Zamboni, Mark N. Kirstein, Ming Tan, Tiebin Liu
Clinical Cancer Research. 2003-02-01
Journal Articles
- Immunoregulatory Protein B7-H3 Regulates Cancer Stem Cell Enrichment and Drug Resistance Through MVP-Mediated MEK ActivationMing Tan, MD, Nature
Press Mentions
Blue Water Vaccines Announces Signing of Sponsored Research Agreement with Cincinnati Children’s Hospital Medical Center for S&P Vaccine Platform DevelopmentJuly 20th, 2022- Blue Water Vaccines Announces the Appointment of Ronald R. Cobb as the Head of Science and DiscoveryAugust 11th, 2021
- Blue Water Vaccines Announces Exclusive, Global License Agreement of Novel Versatile Vaccine Platform from Cincinnati Children's Hospital Medical CenterJuly 13th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
